ASPIRE BIOPHARMA HLDGS INC
Q1 2026 13F Holders
Symbol
ASBP
CUSIP
738920206
Type
Equity
Class
COM
Num filings
13
Total reported value, excl. options
$363 k
Compare 2026 Q1 to
Manager
Report Date
Value ($000)
Shares
Option Type